Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance

Autor: Peyton Jacob, Evangelia Liakoni, Rachel F. Tyndale, Delia A. Dempsey, Newton Addo, Neal L. Benowitz
Rok vydání: 2021
Předmět:
0301 basic medicine
Saliva
Metabolite
Glucuronidation
Urine
030226 pharmacology & pharmacy
Nicotine
chemistry.chemical_compound
0302 clinical medicine
nicotine metabolite ratio
Pharmacology & Pharmacy
Glucuronosyltransferase
General Pharmacology
Toxicology and Pharmaceutics

610 Medicine & health
Cotinine
Genetics (clinical)
media_common
African Americans
Smoking
Pharmacology and Pharmaceutical Sciences
racial differences
Molecular Medicine
nicotine clearance
Glucuronide
medicine.drug
medicine.medical_specialty
Genotype
media_common.quotation_subject
Article
03 medical and health sciences
Glucuronides
Internal medicine
Tobacco
Genetics
medicine
Humans
cotinine
Molecular Biology
Tobacco Smoke and Health
business.industry
Addiction
glucuronidation
Brain Disorders
Black or African American
Good Health and Well Being
030104 developmental biology
Endocrinology
chemistry
business
Zdroj: Pharmacogenetics and genomics, vol 31, iss 5
Pharmacogenet Genomics
Liakoni, Evangelia; Tyndale, Rachel F; Jacob, Peyton; Dempsey, Delia A; Addo, Newton; Benowitz, Neal L (2021). Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance. Pharmacogenetics and genomics, 31(5), pp. 97-107. Lippincott Williams & Wilkins 10.1097/FPC.0000000000000427
ISSN: 1744-6872
Popis: Author(s): Liakoni, Evangelia; Tyndale, Rachel F; Jacob, Peyton; Dempsey, Delia A; Addo, Newton; Benowitz, Neal L | Abstract: ObjectivesTo investigate if the nicotine metabolite ratio (NMR, the ratio of nicotine metabolites 3'-hydroxycotinine/cotinine) is a reliable phenotypic biomarker for nicotine clearance across races, and as a function of differences in the rate of nicotine, cotinine and 3'-hydroxycotinine glucuronidation and UGT genotypes.MethodsParticipants [Caucasians (Whites), African Americans (Blacks) and Asian-Americans (Asians)] received an oral solution of deuterium-labeled nicotine and its metabolite cotinine. Plasma and saliva concentrations of nicotine and cotinine were used to determine oral clearances. Rates of glucuronidation were assessed from urine glucuronide/parent ratios, and UGT2B10 and UGT2B17 genotypes from DNA.ResultsAmong the 227 participants, 96 (42%) were White, 67 (30%) Asian and 64 (28%) Black. Compared to the other two races, Whites had higher nicotine and cotinine total oral clearance, Blacks had lower nicotine and cotinine glucuronidation rates and Asians had lower 3'-hydroxycotinine glucuronidation rates. A strong positive correlation (correlations coefficients 0.77-0.84; P l 0.001) between NMR and nicotine oral clearance was found for all three races, and NMR remained a strong predictor for the nicotine oral clearance while adjusting for race, sex and age. Neither the metabolite glucuronidation ratios nor the UGT genotypes had significant effects on the ability of NMR to predict nicotine oral clearance.ConclusionNMR appears to be a reliable phenotypic biomarker for nicotine clearance across races, glucuronidation phenotypes and genotypes. Racial differences in the relationships between NMR, smoking behaviors and addiction are unlikely to be related to an inadequate estimation of nicotine clearance on the basis of NMR.
Databáze: OpenAIRE